Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Organisation › Details

Sygnis Pharma AG

SYGNIS Pharma AG (Heidelberg, Germany) is a biotech company listed in the Prime Standard of the German Stock Exchange (Ticker: LIO1; ISIN: DE000A1RFM03). According to the 2012 newly defined business strategy, the company focuses on the development and marketing of novel technologies in molecular biology, e.g. in the field of DNA amplification and sequencing. For the key product "Qualiphi®", an improved polymerase for amplifying DNA, an exclusive worldwide license has been granted to Qiagen in July 2012. *

 

Period Start 2008-06-09 existent
  Group Expedeon (Group)
  Today Sygnis AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard)
  Successor Sygnis AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard)
Product Industry drug discovery
Person Person de la Huerta Martinez, Pilar (Sygnis Pharma 201303– CEO + CFO before Genetrix CEO before Zeltia)
     
Region Region Heidelberg
  Country Germany
  Street 515 Im Neuenheimer Feld
  City 69120 Heidelberg
  Tel +49-62214546
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency EUR
  Annual sales 200,000 (revenues, mainly X-Pol (2012) 2012-12-31)
  Profit -2,400,000 (2012-12-31)
  Cash 500,000 (2012-12-31)
     
    * Document for �About Section�: Sygnis Pharma AG. (12/20/12). "Press Release: Sygnis Announces the Adaptation of Its Organisation to the New Business Activity". Heidelberg.
     
   
Record changed: 2019-12-03

Advertisement

Picture [iito] Männer Ballett 650x80px

More documents for Expedeon (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] Made Without Love 650x80px




» top